Role of Real-World Evidence in Oncology Drug Registration and Commercialization

Looking forward to this session? Share it!

• Discuss the evolving nature of US environment leading to an increase in use of Real-World Evidence (RWE)
• Evaluate the role of RWE in Oncology Product Registration in the US

• Identify opportunities in leveraging RWE to support access, reimbursement, and commercialization in the US